Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial Hypertension
Top Cited Papers
- 30 June 2009
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 54 (1), S78-S84
- https://doi.org/10.1016/j.jacc.2009.04.017
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation, 2009
- Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension: A Randomized TrialYearbook of Cardiology, 2009
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertensionEuropean Heart Journal, 2008
- Sitaxsentan: a selective endothelin-A receptor antagonist, for the treatment of pulmonary arterial hypertensionExpert Opinion on Pharmacotherapy, 2006
- Ambrisentan Therapy for Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2005
- Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial HypertensionCirculation, 2005
- Clinical efficacy of sildenafil in primary pulmonary hypertension: A randomized, placebo-controlled, double-blind, crossover studyJournal of the American College of Cardiology, 2004
- Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertensionJournal of the American College of Cardiology, 2003
- Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled studyThe Lancet, 2001
- Primary pulmonary hypertension: natural history and the importance of thrombosis.Circulation, 1984